Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for allosteric PARP-1 retention on DNA breaks
Levani Zandarashvili, Marie-France Langelier, Uday Kiran Velagapudi, et al.
Science (2020) Vol. 368, Iss. 6486
Open Access | Times Cited: 265

Showing 1-25 of 265 citing articles:

Targeting DNA damage response pathways in cancer
Florian J. Groelly, Matthew Fawkes, Rebecca A. Dagg, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 78-94
Closed Access | Times Cited: 427
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 396
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias, Sarah C. Moser, Shridar Ganesan, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 773-791
Closed Access | Times Cited: 347
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Neeraj Agarwal, Arun Azad, Joan Carles, et al.
The Lancet (2023) Vol. 402, Iss. 10398, pp. 291-303
Closed Access | Times Cited: 281
Massively parallel assessment of human variants with base editor screens
Ruth E. Hanna, Mudra Hegde, Christian Fagre, et al.
Cell (2021) Vol. 184, Iss. 4, pp. 1064-1080.e20
Open Access | Times Cited: 249
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 9, pp. 1250-1264
Closed Access | Times Cited: 228
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 155
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance
Dae-Seok Kim, Cristel V. Camacho, W. Lee Kraus
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 1, pp. 42-51
Open Access | Times Cited: 126
CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
Yu Zhang, Jiajia Jiang, Jiayin Zhang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 111
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
Dragomir B. Krastev, Shudong Li, Yilun Sun, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 62-73
Open Access | Times Cited: 110
Inhibitors of PARP: Number crunching and structure gazing
Johannes Rudolph, Karen Jung, Karolin Luger
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 83
PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s disease
Hyejin Park, Tae‐In Kam, Hanjing Peng, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1943-1959.e21
Open Access | Times Cited: 69
ADP-ribosylation from molecular mechanisms to therapeutic implications
Marcin J. Suskiewicz, Evgeniia Prokhorova, J.G.M. Rack, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4475-4495
Open Access | Times Cited: 67
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
Michalis Petropoulos, Angeliki Karamichali, Giacomo G. Rossetti, et al.
Nature (2024) Vol. 628, Iss. 8007, pp. 433-441
Open Access | Times Cited: 54
PARP1 associates with R-loops to promote their resolution and genome stability
Natalie Laspata, Parminder Kaur, Sofiane Y. Mersaoui, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 5, pp. 2215-2237
Open Access | Times Cited: 47
PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends
Nagaraja Chappidi, Thomas Quail, Simon Doll, et al.
Cell (2024) Vol. 187, Iss. 4, pp. 945-961.e18
Open Access | Times Cited: 46
A new wave of innovations within the DNA damage response
Qi Li, Wenyuan Qian, Yang Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Base Excision Repair: Mechanisms and Impact in Biology, Disease, and Medicine
Dhara Gohil, Altaf H. Sarker, Rabindra Roy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14186-14186
Open Access | Times Cited: 40
Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
Silvija Bilokapić, Marcin J. Suskiewicz, Ivan Ahel, et al.
Nature (2020) Vol. 585, Iss. 7826, pp. 609-613
Open Access | Times Cited: 118
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
Chiho Kim, Xudong Wang, Yonghao Yu
eLife (2020) Vol. 9
Open Access | Times Cited: 98
Rapid Detection and Signaling of DNA Damage by PARP-1
Nootan Pandey, Ben E. Black
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 9, pp. 744-757
Open Access | Times Cited: 88
The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks
Charlotte Blessing, Imke K. Mandemaker, Claudia Gonzalez-Leal, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 862-875.e6
Open Access | Times Cited: 85
Base excision repair and its implications to cancer therapy
Gabrielle J. Grundy, Jason L. Parsons
Essays in Biochemistry (2020) Vol. 64, Iss. 5, pp. 831-843
Open Access | Times Cited: 82
CARM1 regulates replication fork speed and stress response by stimulating PARP1
Marie‐Michelle Genois, Jean‐Philippe Gagné, Takaaki Yasuhara, et al.
Molecular Cell (2021) Vol. 81, Iss. 4, pp. 784-800.e8
Open Access | Times Cited: 80
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top